Spliceosome Mutant Myeloid Malignancies Are Preferentially Sensitive to PARP Inhibition von Nguyen, Dang Hai, Liu, Zhiyan Silvia, Sinha, Sayantani, Bannister, Maxwell, Arriaga-Gomez, Erica, Song, Axia, Zong, Dawei, Corral, Victor, Leibson, Cassandra, Rai, Sumit, Graubert, Timothy A., Lee, Stanley C

Volltext

Therapeutic Targeting of Spliceosome Mutant Myeloid Neoplasms Via PARP1 Inhibition von Sinha, Sayantani, Liu, Zhiyan Silvia, Bannister, Maxwell, Arriaga-Gomez, Erica, Song, Axia, Zong, Dawei, Sarchi, Martina, Bonner, Elizabeth, Corral, Victor, Leibson, Cassandra, Chiraphapphaiboon, Wannasiri, Stirewalt, Derek, Deeg, Joachim, Rai, Sumit, Walter, Matthew J, Graubert, Timothy A., Doulatov, Sergei, Nguyen, Dang Hai, Lee, Stanley Chun-Wei

Volltext

Abstract 6183: PARP inhibitors preferentially sensitize splicing factor mutant myeloid neoplasms von Nguyen, Dang Hai, Sinha, Sayantani, Liu, Zhiyan Silvia, Bannister, Maxwell Henry, Arriaga-Gomez, Erica, Song, Axia, Zong, Dawei, Sarchi, Martina, Corral, Victor, Chiraphapphaiboon, Wannasiri, Yoo, Jennifer, McMahon, Matthew, Leibson, Cassandra, Stirewalt, Derek L., Deeg, H Joachim, Rai, Sumit, Walter, Matthew, Graubert, Timothy A., Doulatov, Sergei, Lee, Stanley C.

Volltext